2ACCILI D,NAKAE J,KIM J J,et al.Targeted gene mutationsdefine the roles of insulin and IGF-I receptors in mouse embryonic development[J].J Pediatr Endocrinol Metab,1999,12:475-485.
3VELDHUIS J D,LIEM A Y,SOUTH S,et al.Differential impact of age,sex steroid hormones,and obesity on basalversus pulsatile growth hormone secretion in men as assessed inan ultrasensitive chemiluminescence assay[J].J Clin Endocrinol Metab,1995,80:3209-3222.
4METZGER DL,KERRIGAN J R,ROGOL A D,et al.Gonadal steroid hormone regulation of the somtotrophic axis during puberty in humans[J].Trends Endocrinol Metab,1994,5:290-296.
5DiMARTINO-NARDI J,WU R,VARNER R,et al.The effect of luteinizing hormone-releasing hormone analog for central precociouspuberty on growth hormone (GH) and GH-binding protein[J].J Clin Endocrinol Metab,1994,78:664-668.
6HARRIS DA,van VLIET G,EGLI C A,et al.Somatomedin-C in normal puberty and in true precocious puberty before and after treatment witha potent luteinizing hormone-releasing hormone agonist[J].J Clin Endocrinol Metab,1985,61:152-159.
7SKLAR CA,ROTHENBERG S,BLUMBERG D,et al.Suppression of the pituitary-gonadal axis in children with central precocious puberty:effects on growth,growth hormone,insulin-like growth factor-I,and prolactin secretion[J].J Clin Endocrinol Metab,1991,73:734-738.
8GALLUZZI F,SALTI R,BINDI G,et al.Adult height comparison between boys and girls with precocious puberty after longterm gonadotropin-releasing hormone analogue therapy[J].Acta Paediatr,1998,87:521-527.
9SAGGESE G,PASQUINO A M,BERTELLONI S,et al.Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis[J].Acta Paediatr,1995,84:299-304.
10TATO′L,SAGGESE G,CAVALLO L,et al.Use of combined Gn-RH agonist and hGH therapy for better attaining the goals in precocious puberty treatment[J].Horm Res,1995,44:49-54.
